NCT05700903 2026-03-02
ARCH
University of Colorado, Denver
Phase 4 Completed
Clinical Trials
32 trialsNCT02964078 2026-02-10
Interleukin-2 and Pembrolizumab for Metastatic Kidney Cancer
H. Lee Moffitt Cancer Center and Research Institute
Phase 2 Completed
NCT02684006 2025-07-30
JAVELIN Renal 101
Pfizer
Phase 3 Completed
NCT03767517 2025-05-23
A Culturally-Based Palliative Care Tele-consult Program for Rural Southern Elders
University of Alabama at Birmingham
Phase NA Completed
NCT04037436 2025-04-13
MoveStrong
University of Waterloo
Phase NA Completed
NCT04066153 2025-04-06
Patient Reported Unmet Needs for Function and Supportive Occupational- and Physiotherapy Rehabilitation Interventions
Rigshospitalet, Denmark
Completed
NCT04009668 2024-10-30
Tumor Necrosis Factor Inhibition in Focal Segmental Glomerulosclerosis and Treatment Resistant Minimal Change Disease
University of Michigan
Phase 2 Completed
NCT04005183 2024-10-10
REMEDY
University Health Network, Toronto
Completed
NCT02301117 2024-09-05
A Phase I Study of TAS-102 in Patients With Advanced Solid Tumors With Renal Impairment
Taiho Oncology, Inc.
Phase 1 Completed
NCT01398306 2024-05-06
BANN
University Medical Center Groningen
Completed
NCT04594161 2024-02-28
STONE
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Phase NA Completed
NCT02429479 2024-01-26
Preparing Family Caregivers to Make Medical Decisions for Their Loved Ones
Milton S. Hershey Medical Center
Phase NA Completed
NCT03960437 2023-09-21
Parsabiv-MBD
Columbia University
Phase 2 Completed
NCT02742597 2023-03-17
PACEinMM-ON
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Phase NA Completed
NCT04185454 2023-01-11
Estimation of Minimum Efficacy Daily Dose of Jarlsberg Cheese
Meddoc
Phase NA Completed
NCT01429038 2022-06-14
Mesenchymal Stem Cells After Renal or Liver Transplantation
University of Liege
Phase 1/2 Completed
NCT02329808 2022-05-10
PROTECT
Radboud University Medical Center
Completed
NCT02822404 2022-04-25
CysPed
University Hospital, Toulouse
Phase NA Completed
NCT02493751 2022-02-18
JAVELIN Renal 100
Pfizer
Phase 1 Completed
NCT04704349 2021-11-03
LISSE1
Centre Hospitalier Régional d'Orléans
Phase NA Completed
NCT03394859 2020-05-28
eMERGE
Vanderbilt University Medical Center
Completed
NCT01331941 2017-11-06
A Pharmacokinetic Study of AMG 386 in Cancer Subjects With Normal and Impaired Renal Function
Amgen
Phase 1 Completed
NCT00854620 2015-06-19
Safety and Toxicity Study of Sorafenib in Patients With Kidney Cancer
Stanford University
Phase 2 Completed
NCT00753415 2015-03-17
A Study of V934/V935 Vaccine in Cancer Participants With Selected Solid Tumors (V934-002)
Merck Sharp & Dohme LLC
Phase 1 Completed
NCT00939146 2014-02-07
Outlook: An Intervention to Improve Quality of Life in Serious Illness
Duke University
Phase NA Completed
NCT01210716 2013-09-23
Evaluation of Therapeutic Plasma Exchange (TPE) Procedure Using the AMICUS Device
Fenwal, Inc.
Phase 3 Completed
NCT01441661 2013-03-18
Sunitinib Intake Conditions in the Treatment of Patients With Renal Cell Carcinoma
Cancer Foundation, China
Completed
NCT00062621 2013-02-05
Combined Bone Marrow and Kidney Transplant for Multiple Myeloma With Kidney Failure
National Institute of Allergy and Infectious Diseases (NIAID)
Phase 1 Completed
NCT00526331 2012-01-16
Evaluation of Arterial Pressure Based Cardiac Output for Goal-Directed Perioperative Therapy
M.D. Anderson Cancer Center
Phase 4 Completed
NCT00460798 2010-11-16
SUNIKA
Pfizer
Completed
NCT00001835 2008-03-04
Oxaliplatin in Cancer Patients With Impaired Kidney Function
National Institutes of Health Clinical Center (CC)
Phase 1 Completed
NCT00035334 2006-02-14
Study of the Safety and Efficacy of NC-503 in Secondary (AA) Amyloidosis
Bellus Health Inc. - a GSK company
Phase 2/3 Completed